Open AccessDecreased Circulating Dipeptidyl Peptidase-4 Enzyme Activity Is Prognostic for Severe Outcomes in Covid-19 Inpatients
Author(s) -
Ákos Nádasdi,
György Sinkovits,
Ilona Bobek,
Botond Lakatos,
Zsolt Förhécz,
Zita Z. Prohászka,
Marienn Réti,
Miklós Arató,
Gellért Cseh,
Tamás Masszi,
Béla Merkely,
Péter Ferdinandy,
István VályiNagy,
Zoltán Prohászka,
Gábor Firneisz
Publication year - 2022
Publication title -
biomarkers in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.652
H-Index - 44
eISSN - 1752-0371
pISSN - 1752-0363
DOI - 10.2217/bmm-2021-0717
Subject(s) - medicine , dipeptidyl peptidase 4 , covid-19 , dipeptidyl peptidase , neprilysin , enzyme , virology , diabetes mellitus , endocrinology , type 2 diabetes , disease , biochemistry , chemistry , outbreak , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom